Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches.

T helper lymphocytes can be divided into two distinct subsets of effector cells based on their functional capabilities and the profile of cytokines they produce. The Th1 subset of CD4+ T cells secretes cytokines usually associated with inflammation, such as IFN-gamma and TNF and induces cell-mediated immune responses. The Th2 subset produces cytokines such as IL-4 and IL-5 that help B cells to proliferate and differentiate and is associated with humoral-type immune responses. The selective differentiation of either subset is established during priming and can be significantly influenced by a variety of factors. One of these factors, the cytokine environment, has been put forward as the major variable influencing Th development and is already well reviewed by others. Instead, in the current review, we focus on some of the alternative approaches for skewing Th1/Th2 responses. Specifically, we discuss the effects on Th priming of (a) using altered peptide ligands as antigens, (b) varying the dose of antigen, and (c) altering costimulatory signals. The potential importance of each of these variables to influence immune responses to pathogens in vivo is discussed throughout.

[1]  D. Mcmahon-Pratt,et al.  Leishmania‐infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cells , 1996, European journal of immunology.

[2]  E. Fuchs,et al.  CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. , 1996, Immunity.

[3]  N. Glaichenhaus,et al.  Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages. , 1996, Journal of immunology.

[4]  Li-Fang Wang,et al.  Epicutaneous exposure of protein antigen induces a predominant Th2-like response with high IgE production in mice. , 1996, Journal of immunology.

[5]  J. Bluestone,et al.  CD28/B7 system of T cell costimulation. , 1996, Annual review of immunology.

[6]  A. Sette,et al.  Peptide analogs with different affinites for MHC alter the cytokine profile of T helper cells. , 1996, International immunology.

[7]  N. Ganguly,et al.  Macrophage‐T cell interaction in murine salmonellosis: selective down‐regulation of ICAM‐1 and B7 molecules in infected macrophages and its probable role in cell‐mediated immunity , 1996, European journal of immunology.

[8]  P. Allen,et al.  Endogenous altered peptide ligands can affect peripheral T cell responses , 1996, The Journal of experimental medicine.

[9]  M. Sarzotti,et al.  Induction of Protective CTL Responses in Newborn Mice by a Murine Retrovirus , 1996, Science.

[10]  T. Mosmann,et al.  The expanding universe of T-cell subsets: Th1, Th2 and more. , 1996, Immunology today.

[11]  I. Müller,et al.  Susceptibility to Leishmania major Infection in Interleukin-4-Deficient Mice , 1996, Science.

[12]  L. Adorini,et al.  Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)- microglobulin-deficient BALB/c mice , 1996, The Journal of experimental medicine.

[13]  P. Allen,et al.  Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. , 1996, Annual review of immunology.

[14]  J. Woodgett,et al.  CD28 signal transduction pathways. A comparison of B7-1 and B7-2 regulation of the map kinases: ERK2 and Jun kinases. , 1996, Molecular immunology.

[15]  P. Linsley,et al.  CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. , 1995, Journal of immunology.

[16]  H. Griesser,et al.  Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4 , 1995, Science.

[17]  J. Bluestone,et al.  Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. , 1995, Immunity.

[18]  A. Woodard,et al.  Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells , 1995, The Journal of experimental medicine.

[19]  M. Feldmann,et al.  Critical role of CD28/B7 costimulation in the development of human Th2 cytokine-producing cells. , 1995, Blood.

[20]  K. Murphy,et al.  The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model , 1995, The Journal of experimental medicine.

[21]  V. Maino,et al.  Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations , 1995, The Journal of experimental medicine.

[22]  J. West,et al.  B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. , 1995, Journal of immunology.

[23]  A. Sette,et al.  Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon gamma by T cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[24]  V. Kuchroo,et al.  An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. , 1995, Immunity.

[25]  B. Smith,et al.  CD4 and CD45 regulate qualitatively distinct patterns of calcium mobilization in individual CD4+ T cells , 1995, European journal of immunology.

[26]  N. Ganguly,et al.  Macrophage‐T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmania‐infected macrophages and its implication in the suppression of cell‐mediated immunity , 1995, European journal of immunology.

[27]  C Danieli,et al.  Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products , 1995, The Journal of experimental medicine.

[28]  C. Thompson,et al.  CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. , 1995, Immunity.

[29]  J. Bluestone New perspectives of C1328-137-mediated T cell costimulation , 1995 .

[30]  R. Flavell,et al.  Peptide and protein antigens require distinct antigen-presenting cell subsets for the priming of CD4+ T cells. , 1995, Journal of immunology.

[31]  R. Steinman,et al.  The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing , 1995, Nature.

[32]  J. Gribben,et al.  B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. , 1995, Immunity.

[33]  M. Croft,et al.  Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines. , 1995, Journal of immunology.

[34]  P. Linsley,et al.  CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2 , 1995, The Journal of experimental medicine.

[35]  A. Sette,et al.  Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. , 1995, Immunity.

[36]  A. Sette,et al.  Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo , 1995, The Journal of experimental medicine.

[37]  Laurie H Glimcher,et al.  B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy , 1995, Cell.

[38]  M. Peters Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells , 1995 .

[39]  D. Umetsu,et al.  Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type , 1995, The Journal of experimental medicine.

[40]  J. Bluestone,et al.  Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse , 1995, The Journal of experimental medicine.

[41]  C. June,et al.  CD28 activation promotes Th2 subset differentiation by human CD4+ cells , 1995, European journal of immunology.

[42]  L. Samelson,et al.  Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists , 1995, Science.

[43]  P. Linsley,et al.  CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. , 1995, Journal of immunology.

[44]  A. Bendelac Mouse NK1+ T cells. , 1995, Current opinion in immunology.

[45]  Paul M. Allen,et al.  Partial T cell signaling: Altered phospho-ζ and lack of zap70 recruitment in APL-induced T cell anergy , 1994, Cell.

[46]  K. Else,et al.  Low‐level infection with Trichuris muris significantly affects the polarization of the CD4 response , 1994, European journal of immunology.

[47]  P. Linsley,et al.  Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. , 1994, Journal of immunology.

[48]  R. Steinman,et al.  The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro , 1994, The Journal of experimental medicine.

[49]  M. Cooke,et al.  Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. , 1994, Journal of immunology.

[50]  P. Linsley,et al.  CTLA-4 can function as a negative regulator of T cell activation. , 1994, Immunity.

[51]  P. Linsley,et al.  Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function , 1994, The Journal of experimental medicine.

[52]  P. Linsley,et al.  CTLA-4 ligands are required to induce an in vivo interleukin 4 response to a gastrointestinal nematode parasite , 1994, The Journal of experimental medicine.

[53]  A. Sette,et al.  Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells , 1994, Nature.

[54]  Sarah Rowland-Jones,et al.  Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants , 1994, Nature.

[55]  A. Abbas,et al.  Costimulator dependence of lymphokine secretion by naive and activated CD4+ T lymphocytes from TCR transgenic mice. , 1994, Journal of immunology.

[56]  J. West,et al.  Are primed CD4+ T lymphocytes different from unprimed cells? , 1994, European journal of immunology.

[57]  N. Nabavi,et al.  In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2. , 1994, Immunity.

[58]  R. Schwartz,et al.  A subset of CD4+ thymocytes selected by MHC class I molecules. , 1994, Science.

[59]  P. Linsley,et al.  CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon gamma production , 1994, The Journal of experimental medicine.

[60]  S. Romagnani Lymphokine production by human T cells in disease states. , 1994, Annual review of immunology.

[61]  W. Paul,et al.  Acquisition of lymphokine-producing phenotype by CD4+ T cells. , 1994, Annual review of immunology.

[62]  R. Flavell,et al.  The relationship of IL-4- and IFNγ-producing T cells studied by lineage ablation of IL-4-producing cells , 1993, Cell.

[63]  A. Sher,et al.  Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Kenneth M. Murphy,et al.  Dendritic cells and macrophages are required for Th1 development of CD4+ T cells from αβ TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-γ production is IFN-γ-dependent , 1993 .

[65]  F. Finkelman,et al.  Brucella abortus induces a novel cytokine gene expression pattern characterized by elevated IL-10 and IFN-gamma in CD4+ T cells. , 1993, International immunology.

[66]  K P Lee,et al.  Differential T cell costimulatory requirements in CD28-deficient mice. , 1993, Science.

[67]  P. Scott Selective differentiation of CD4+ T helper cell subsets. , 1993, Current opinion in immunology.

[68]  A. Sher,et al.  Toxoplasma gondii induces a T-independent IFN-gamma response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-alpha. , 1993, Journal of immunology.

[69]  M. Croft,et al.  T-cell memory: new perspectives. , 1993, Immunology today.

[70]  Martin Bachmann,et al.  Disruption of the murine IL-4 gene blocks Th2 cytokine responses , 1993, Nature.

[71]  W. Paul,et al.  Anti-IL-4 diminishes in vivo priming for antigen-specific IL-4 production by T cells. , 1993, Journal of immunology.

[72]  P. Linsley,et al.  The role of the CD28 receptor during T cell responses to antigen. , 1993, Annual review of immunology.

[73]  P. Linsley,et al.  Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4 , 1992, Cell.

[74]  P. Linsley,et al.  Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes , 1992, The Journal of experimental medicine.

[75]  Giorgio,et al.  Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells , 1992, The Journal of experimental medicine.

[76]  W. Paul,et al.  The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice , 1992, The Journal of experimental medicine.

[77]  D. Katz,et al.  Antigen concentration determines helper T cell subset participation in IgE antibody responses. , 1992, Cellular immunology.

[78]  H. Bielefeldt-Ohmann,et al.  Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. , 1992, Science.

[79]  C. Hsieh,et al.  Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[80]  C. Heusser,et al.  Bee venom phospholipase A2‐specific T cell clones from human allergic and non‐allergic individuals: cytokine patterns change in response to the antigen concentration , 1992, European journal of immunology.

[81]  K. Bottomly,et al.  Major histocompatibility complex (MHC) control of CD4 T cell subset activation. II. A single peptide induces either humoral or cell‐mediated responses in mice of distinct MHC genotype , 1992, European journal of immunology.

[82]  M. Davis,et al.  Molecular components of T-cell recognition. , 1992, Annual review of immunology.

[83]  W. Paul,et al.  Mouse splenic and bone marrow cell populations that express high-affinity Fc epsilon receptors and produce interleukin 4 are highly enriched in basophils. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[84]  R. Locksley,et al.  Induction of Th1 and Th2 CD4+ subsets during murine Leishmania major infection. , 1991, Research in immunology.

[85]  A. Weinberg,et al.  IL-4 directs the development of Th2-like helper effectors. , 1990, Journal of immunology.

[86]  F. Finkelman,et al.  Anti-CD3 antibody induces rapid expression of cytokine genes in vivo. , 1990, Journal of immunology.

[87]  W. Paul,et al.  Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4- producing cells , 1990, The Journal of experimental medicine.

[88]  S. Carding,et al.  MHC control of CD4+ T cell subset activation , 1989, The Journal of experimental medicine.

[89]  B. Torbett,et al.  A new murine CD4+ T cell subset with an unrestricted cytokine profile. , 1989, Journal of immunology.

[90]  W. Paul,et al.  Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores , 1989, Nature.

[91]  A. Woods,et al.  Differential activation of cytokine genes in normal CD4‐bearing T cells is stimulus dependent , 1989, European journal of immunology.

[92]  R. Stout,et al.  Antigen-specific activation of effector macrophages by IFN-gamma producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages. , 1989, Journal of immunology.

[93]  R. Locksley,et al.  Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets , 1989, The Journal of experimental medicine.

[94]  E. Unanue,et al.  Intracellular interference with antigen presentation. , 1988, Journal of immunology.

[95]  J. Abrams,et al.  Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones. , 1988, Journal of immunology.

[96]  R. Coffman,et al.  The Role of Helper T Cell Products in Mouse B Cell Differentiation and Isotype Regulation , 1988, Immunological reviews.

[97]  T. Mosmann,et al.  Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. , 1987, Journal of immunology.

[98]  A. Woods,et al.  Cloned, Ia-restricted T cells that do not produce interleukin 4(IL 4)/B cell stimulatory factor 1(BSF-1) fail to help antigen-specific B cells. , 1987, Journal of immunology.

[99]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[100]  B. Benacerraf,et al.  T cell development in B cell-deficient mice. IV. The role of B cells as antigen-presenting cells in vivo. , 1986, Journal of immunology.

[101]  A. Woods,et al.  Distinct functional phenotypes of cloned Ia-restricted helper T cells , 1985, The Journal of experimental medicine.

[102]  F. Liew,et al.  IMMUNE RESPONSE TO CHEMICALLY MODIFIED FLAGELLIN III. ENHANCED CELL-MEDIATED IMMUNITY DURING HIGH AND LOW ZONE ANTIBODY TOLERANCE TO FLAGELLIN , 1972 .